odmj
OncoDaily Medical Journal
ODMJ
3067-6444
OncoDaily Medical Journal
US
340
10.69690/ODMJ-002-0425-340
Reviews
Gastrointestinal oncology in Mexico
https://orcid.org/0000-0002-4784-1793
Noguez-Ramos
Alejandro
Medical Oncologist. Gastrointestinal Oncologist. Head of research ABC Medical Center, Mexico City
dralejandronoguez@gmail.com
Wuotto-Alvarado
Susy
Medical Oncology Fellow, ABC Medical Center, Mexico City
https://orcid.org/0000-0002-0461-0362
Fuente-Rivera
José Alfonso de la
Physician, ABC Medical Center, Mexico City
Valadez-Haro
María Fernanda Macías
Medical student, Universidad Anáhuac México
01
04
2025
ODMJ-002-0425-340
Copyright (c) 2025 OncoDaily Medical Journal
2025
OncoDaily Medical Journal
Gastrointestinal cancer
Gastrointestinal oncology
Mexico
production-ready-file-url
[
International Agency for Research on Cancer (IARC). Global Cancer Observatory [Internet]. 2024 [cited 2024 Dec].
]
[
Sáenz R, Santander R, Navarrete C, et al. Is this the time for the gastroenterologist oncologist? A new sub-specialty for the comprehensive management of digestive cancer. Gastroenterol Latinoam. 2012;23(2):98-104.
]
[
André T, Shiu KK, Kim TW, et al. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. PMID: 33264544.
]
[
Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021 Jul 3;398(10294):27-40. doi: 10.1016/S0140-6736(21)00797-2. Epub 2021 Jun 5. PMID: 34102137; PMCID: PMC8436782.
]
[
Oh DY, Ruth He A, Qin S, et al. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer. NEJM Evid. 2022 Aug;1(8):EVIDoa2200015. doi: 10.1056/EVIDoa2200015. Epub 2022 Jun 1. PMID: 38319896.
]
[
Cheng AL, Qin S, Ikeda M, et al. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. J Hepatol. 2022 Apr;76(4):862-873. doi: 10.1016/j.jhep.2021.11.030. Epub 2021 Dec 11. PMID: 34902530.
]
[
Golan T, Hammel P, Reni M, et al. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2. PMID: 31157963; PMCID: PMC6810605.
]
[
Kopetz S, Yoshino T, Van Cutsem E, et al. Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial. Nat Med. 2025 Jan 25. doi: 10.1038/s41591-024-03443-3. Epub ahead of print. PMID: 39863775.
]
[
Brau-Figueroa Hasan, Palafox-Parrilla E. Alejandra, Mohar-Betancourt Alejandro. El Registro Nacional de Cáncer en México, una realidad. Gac. mex. oncol. [Internet]. 2020 Sep [cited 2025 Mar 03] ; 19( 3 ): 107-111. Available from:
]
[
Acevedo-Ibarra JN, Juárez-García DM, Espinoza-Velazco A, Buenaventura-Cisneros S. Quality of life in Mexican colorectal cancer patients: analysis with sociodemographic, medical, and psychological variables. Psychol Health Med. 2021 Aug;26(7):853-866. doi: 10.1080/13548506.2020.1807578. Epub 2020 Aug 28. PMID: 32857614.
]
[
Sánchez Morales GE, Moguel Valladares RA, Flores Maza J, Clemente Gutiérrez U, Sánchez-García Ramos E, Domínguez Rosado I, et al. Pancreatic ductal adenocarcinoma: Eleven years of experience at a tertiary care hospital center. Revista de Gastroenterología de México. 2021;86(2):118–24.
]
[
González-León Margot, Fernández-Gárate José Esteban, Rascón-Pacheco Ramón Alberto, Valladares-Aranda Miguel Ángel, Dávila-Torres Javier, Borja-Aburto Víctor Hugo. The burden of disease of cancer in the Mexican Social Security Institute. Salud pública Méx [Internet]. 2016 Abr [cited 2025 Mar 03] ; 58( 2 ): 132-141.
]
[
Flisser A. La medicina en México hacia el siglo XX. Gac Med Mex. 2009;145(4):353-6.
]
[
Loyo-Varela M, Díaz-Cházaro H. Hospitales en México. Cir Cir [Internet]. 2009;77(6):497-504.
]
[
Méndez JS. Análisis del presupuesto en salud rumbo a 2030 [Internet]. México: CIEP; 2024 [cited 2024 Dec 9].
]
[
Instituto Mexicano del Seguro Social (IMSS). Aprueba H. Consejo Técnico del IMSS sustitución de 12 aceleradores lineales [Internet]. 2024 [cited 2024 Dec].
]
[
Ávila-Rodríguez M, Rivera-Bravo B, Kerik-Rotenberg NE, et al. Estado actual y perspectivas de la imagen molecular PET en México. Gac Med Mex. 2019;155(4):436-7.
]
[
Brau H, Palafox A, Parrilla P, et al. Infraestructura oncológica en el Sistema de Salud Mexicano. Salud Publica Mex.2022;64(1):105-6.
]
[
Secretaría de Salud. Instituto Nacional de Cancerología, referente en atención oncológica: JAV [Internet]. 2021 [cited 2024 Dec].
]
[
Instituto Nacional de Estadística y Geografía (INEGI). Censo de Población y Vivienda 2020 [Internet]. 2020 [cited 2024 Dec].
]
[
Torres-Lobatón A. Oncology at General Hospital of Mexico: its origins. Rev Med Hosp Gen Méx [Internet]. 2021 Mar;84(1):41-8.
]
[
Universidad Nacional Autónoma de México. Posgrados de alta especialidad en medicina [Internet]. 2024 [cited 2024 Nov 20].
]
[
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Dirección de Enseñanza [Internet]. 2024 [cited 2024 Nov 20].
]